Related references
Note: Only part of the references are listed.Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer
Giulia Petroni et al.
CLINICAL CANCER RESEARCH (2021)
Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma
Tong-Hong Wang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
Erica L. Mayer et al.
LANCET ONCOLOGY (2021)
Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature
Steven David et al.
TRANSLATIONAL ONCOLOGY (2021)
Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma
Bethany Veo et al.
CELL REPORTS (2021)
CDK 4/6 inhibitors combined with radiotherapy: A review of literature
Claire Bosacki et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
Beatriz Salvador-Barbero et al.
CANCER CELL (2020)
Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
Wenxin Zeng et al.
CANCER CELL INTERNATIONAL (2020)
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination
Benjamin C. Chandler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists
Alice Y. Ho et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature
Arnaud Beddok et al.
BRITISH JOURNAL OF CANCER (2020)
Antagonizing CDK8 Sensitizes Colorectal Cancer to Radiation Through Potentiating the Transcription of e2f1 Target Gene apaf1
Bin Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows
Patrick J. Roberts et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers
Andrea M. Pesch et al.
CLINICAL CANCER RESEARCH (2020)
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients
Andrea Emanuele Guerini et al.
SCIENTIFIC REPORTS (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
RB Regulates DNA Double Strand Break Repair Pathway Choice by Mediating CtIP Dependent End Resection
Yuning Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Nicole M. Kettner et al.
CLINICAL CANCER RESEARCH (2019)
NATALEE: Phase III study of ribociclib (RIBO) plus endocrine therapy (ET) as adjuvant treatment in hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (EBC).
Dennis J. Slamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
RB1 Deletion in Retinoblastoma Protein Pathway-Disrupted Cells Results in DNA Damage and Cancer Progression
Aren E. Marshall et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
D. M. Fernandez-Aroca et al.
CANCER LETTERS (2019)
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
Anna R. Michmerhuizen et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation
Changhoon Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer
Qingfei Wang et al.
NATURE COMMUNICATIONS (2019)
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
Daniele Cretella et al.
SCIENTIFIC REPORTS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
C. Cruz et al.
ANNALS OF ONCOLOGY (2018)
Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer
Neil O'Brien et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response
Chao-Yuan Huang et al.
EUROPEAN JOURNAL OF CANCER (2018)
DNA methylation profile is associated with the osteogenic potential of three distinct human odontogenic stem cells
Tingting Ai et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss
Yan Gao et al.
CELLULAR ONCOLOGY (2017)
One-step Protocol for Evaluation of the Mode of Radiation-induced Clonogenic Cell Death by Fluorescence Microscopy
Daijiro Kobayashi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer
Zhi Ling Teo et al.
CANCER RESEARCH (2017)
Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors
Debu Tripathy et al.
CLINICAL CANCER RESEARCH (2017)
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Shom Goel et al.
CANCER CELL (2016)
RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1
Renier Velez-Cruz et al.
GENES & DEVELOPMENT (2016)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Direct Involvement of Retinoblastoma Family Proteins in DNA Repair by Non-homologous End-Joining
Rebecca Cook et al.
CELL REPORTS (2015)
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
Lawrence M. Gelbert et al.
INVESTIGATIONAL NEW DRUGS (2014)
RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
Tyler J. W. Robinson et al.
PLOS ONE (2013)
Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition
Jeffry L. Dean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer
Xiaomeng Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair
Meredith A. Morgan et al.
CANCER RESEARCH (2010)
RB•E2F1 Complex Mediates DNA Damage Responses through Transcriptional Regulation of ZBRK1
Ching-Chun Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Analysis of DNA Double-strand Break (DSB) Repair in Mammalian Cells
Andrei Seluanov et al.
Jove-Journal of Visualized Experiments (2010)
Rb Regulates DNA Damage Response and Cellular Senescence through E2F-Dependent Suppression of N-Ras Isoprenylation
Awad Shamma et al.
CANCER CELL (2009)
Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma
L. Maggiorella et al.
CELL PROLIFERATION (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Retinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression
Marcos Seoane et al.
PLOS ONE (2008)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
RB-dependent S-phase response to DNA damage
KE Knudsen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
